TIDAL DIAGNOSTIC SOLUTIONS (TDxS)
Where scientific insight meets an unmet need.
High-performance, ready-to-use, molecular reagents for infectious disease diagnostics.
TDxS MISSION
Solutions for the changing landscape of infectious disease.
Tidal’s mission is to address unmet diagnostic needs with innovative reagents that enable simpler workflows, accelerated detection and improved patient care.
Emerging pathogens
We target new and evolving pathogens to advance diagnostics where solutions are needed most.
Overlooked targets
Tidal is focused on gaps in current diagnostic portfolios that leave clinicians and patients without clear answers.
Partner priorities
Tidal brings experienced scientific strategy and a customer focus to the challenges our collaborators are ready to solve.
TDxS PRODUCTS
Innovative molecular reagents for infectious disease.
Custom designed analyte specific reagents
A growing menu of novel molecular primer and probe pairs
Scalable to all levels of lab throughput
Ask about our new tick-borne disease products
TIDAL WORKS WITH:
o Clinical laboratories
o IVD Manufacturers
o Researchers
o Academic/ Public Health Labs
WHY TDxS
Proven diagnostics experience. Startup responsiveness.
Deep diagnostics expertise
A focused team highly experienced in assay design and performance optimization for trusted, reliable products.
Responsive, Maine-based team
Tidal listens thoughtfully, enabling clear communication and decision-making that keeps work moving.
Quality built into every project
Tidal delivers scalable, GMP product and superior customer support under a QMS built to ISO 13485 regulatory standards.
People who know how to move diagnostics forward.
TDxS LEADERSHIP TEAM
Tidal’s three cofounders bring a combined 70+ years of experience building and scaling high-impact diagnostic solutions.
David Kuhrt, PhD
Dave is a Molecular Virologist and Microbiologist (University of Pittsburgh) turned startup executive with a singular focus: compressing the timeline from research to revenue. With deep roots in diagnostic development and tech transfer, Dave is a hands-on leader who cuts through the noise of traditional R&D to get products into the hands of customers. He champions a culture of intellectual honesty and transparency, where scientific precision meets the agility of a lean startup to rapidly deliver scalable, life-saving solutions.
Chief Executive Officer
Tyler Schleicher, PhD
Tyler’s expertise in microbiology is backed by a strong academic foundation from UConn and Yale, followed by years of hands-on industry experience with molecular diagnostics at small and large companies. He has a proven track record of turning complex science into practical tools like rapid PCR assays and molecular reagents. Driven by creativity and innovation, he is dedicated to advancing how we detect and respond to emerging public health threats.
Chief Scientific Officer
Suzanne has extensive experience in clinical and regulatory strategy, with a proven track record guiding Class 2 and 3 diagnostic devices from concept through FDA submission and commercialization. With an MPH in epidemiology from Yale, Suzanne’s career has spanned leadership roles at global Fortune 500 companies and small startups, Her expertise lies in applying strategic thinking, fostering collaborative teamwork, and ensuring compliance in successfully bringing innovative products to market.
Chief Clinical & Regulatory Officer
Suzanne Vogel, MPH
TDxS PARTNERS
CONTACT TDxS
What diagnostic gap are you working to solve?
The most useful diagnostic solutions begin with a well-defined need. We collaborate early, ask the right questions and build a practical strategy around the challenge.